Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more
Market Cap & Net Worth: Sirona Biochem Corp (SRBCF)
Sirona Biochem Corp (PINK:SRBCF) has a market capitalization of $4.81 Million ($4.81 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #34810 globally and #11371 in its home market, demonstrating a 332.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sirona Biochem Corp's stock price $0.02 by its total outstanding shares 258843825 (258.84 Million).
Sirona Biochem Corp Market Cap History: 2015 to 2025
Sirona Biochem Corp's market capitalization history from 2015 to 2025. Data shows change from $34.35 Million to $4.81 Million (-19.69% CAGR).
Sirona Biochem Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sirona Biochem Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
595.40x
Sirona Biochem Corp's market cap is 595.40 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $34.35 Million | $8.00K | -$3.55 Million | 4296.26x | N/A |
| 2016 | $27.18 Million | $360.50K | -$2.97 Million | 75.39x | N/A |
| 2017 | $23.01 Million | $5.47K | -$4.46 Million | 4208.34x | N/A |
| 2018 | $16.77 Million | $1.28 Million | -$1.27 Million | 13.12x | N/A |
| 2019 | $87.36 Million | $135.74K | -$4.55 Million | 643.57x | N/A |
| 2020 | $67.48 Million | $105.71K | -$4.13 Million | 638.35x | N/A |
| 2021 | $38.05 Million | $268.02K | -$2.31 Million | 141.97x | N/A |
| 2022 | $21.59 Million | $671.92K | -$3.56 Million | 32.13x | N/A |
| 2023 | $20.71 Million | $34.78K | -$2.54 Million | 595.40x | N/A |
Competitor Companies of SRBCF by Market Capitalization
Companies near Sirona Biochem Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Sirona Biochem Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Sirona Biochem Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Sirona Biochem Corp's market cap moved from $34.35 Million to $ 4.81 Million, with a yearly change of -19.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $4.81 Million | -66.61% |
| 2024 | $14.42 Million | -30.38% |
| 2023 | $20.71 Million | -4.08% |
| 2022 | $21.59 Million | -43.27% |
| 2021 | $38.05 Million | -43.61% |
| 2020 | $67.48 Million | -22.76% |
| 2019 | $87.36 Million | +420.83% |
| 2018 | $16.77 Million | -27.11% |
| 2017 | $23.01 Million | -15.33% |
| 2016 | $27.18 Million | -20.87% |
| 2015 | $34.35 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Sirona Biochem Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.81 Million USD |
| MoneyControl | $4.81 Million USD |
| MarketWatch | $4.81 Million USD |
| marketcap.company | $4.81 Million USD |
| Reuters | $4.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.